2024-04-012025-03-312025-03-31false12948539TORTOLOGY LIMITED2025-12-2347770falseiso4217:GBPxbrli:pure129485392024-03-31129485392025-03-31129485392024-04-012025-03-31129485392023-03-31129485392024-03-31129485392023-04-012024-03-3112948539bus:SmallEntities2024-04-012025-03-3112948539bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3112948539bus:FullAccounts2024-04-012025-03-3112948539bus:PrivateLimitedCompanyLtd2024-04-012025-03-3112948539core:WithinOneYear2025-03-3112948539core:AfterOneYear2025-03-3112948539core:WithinOneYear2024-03-3112948539core:AfterOneYear2024-03-3112948539core:ShareCapital2025-03-3112948539core:SharePremium2025-03-3112948539core:RevaluationReserve2025-03-3112948539core:OtherReservesSubtotal2025-03-3112948539core:RetainedEarningsAccumulatedLosses2025-03-3112948539core:ShareCapital2024-03-3112948539core:SharePremium2024-03-3112948539core:RevaluationReserve2024-03-3112948539core:OtherReservesSubtotal2024-03-3112948539core:RetainedEarningsAccumulatedLosses2024-03-3112948539core:LandBuildings2025-03-3112948539core:PlantMachinery2025-03-3112948539core:Vehicles2025-03-3112948539core:FurnitureFittings2025-03-3112948539core:OfficeEquipment2025-03-3112948539core:NetGoodwill2025-03-3112948539core:IntangibleAssetsOtherThanGoodwill2025-03-3112948539core:ListedExchangeTraded2025-03-3112948539core:UnlistedNon-exchangeTraded2025-03-3112948539core:LandBuildings2024-03-3112948539core:PlantMachinery2024-03-3112948539core:Vehicles2024-03-3112948539core:FurnitureFittings2024-03-3112948539core:OfficeEquipment2024-03-3112948539core:NetGoodwill2024-03-3112948539core:IntangibleAssetsOtherThanGoodwill2024-03-3112948539core:ListedExchangeTraded2024-03-3112948539core:UnlistedNon-exchangeTraded2024-03-3112948539core:LandBuildings2024-04-012025-03-3112948539core:PlantMachinery2024-04-012025-03-3112948539core:Vehicles2024-04-012025-03-3112948539core:FurnitureFittings2024-04-012025-03-3112948539core:OfficeEquipment2024-04-012025-03-3112948539core:NetGoodwill2024-04-012025-03-3112948539core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112948539core:ListedExchangeTraded2024-04-012025-03-3112948539core:UnlistedNon-exchangeTraded2024-04-012025-03-3112948539core:MoreThanFiveYears2024-04-012025-03-3112948539core:Non-currentFinancialInstruments2025-03-3112948539core:Non-currentFinancialInstruments2024-03-3112948539dpl:CostSales2024-04-012025-03-3112948539dpl:DistributionCosts2024-04-012025-03-3112948539core:LandBuildings2024-04-012025-03-3112948539core:PlantMachinery2024-04-012025-03-3112948539core:Vehicles2024-04-012025-03-3112948539core:FurnitureFittings2024-04-012025-03-3112948539core:OfficeEquipment2024-04-012025-03-3112948539dpl:AdministrativeExpenses2024-04-012025-03-3112948539core:NetGoodwill2024-04-012025-03-3112948539core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3112948539dpl:GroupUndertakings2024-04-012025-03-3112948539dpl:ParticipatingInterests2024-04-012025-03-3112948539dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3112948539core:ListedExchangeTraded2024-04-012025-03-3112948539dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3112948539core:UnlistedNon-exchangeTraded2024-04-012025-03-3112948539dpl:CostSales2023-04-012024-03-3112948539dpl:DistributionCosts2023-04-012024-03-3112948539core:LandBuildings2023-04-012024-03-3112948539core:PlantMachinery2023-04-012024-03-3112948539core:Vehicles2023-04-012024-03-3112948539core:FurnitureFittings2023-04-012024-03-3112948539core:OfficeEquipment2023-04-012024-03-3112948539dpl:AdministrativeExpenses2023-04-012024-03-3112948539core:NetGoodwill2023-04-012024-03-3112948539core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3112948539dpl:GroupUndertakings2023-04-012024-03-3112948539dpl:ParticipatingInterests2023-04-012024-03-3112948539dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3112948539core:ListedExchangeTraded2023-04-012024-03-3112948539dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3112948539core:UnlistedNon-exchangeTraded2023-04-012024-03-3112948539core:NetGoodwill2025-03-3112948539core:IntangibleAssetsOtherThanGoodwill2025-03-3112948539core:LandBuildings2025-03-3112948539core:PlantMachinery2025-03-3112948539core:Vehicles2025-03-3112948539core:FurnitureFittings2025-03-3112948539core:OfficeEquipment2025-03-3112948539core:AfterOneYear2025-03-3112948539core:WithinOneYear2025-03-3112948539core:ListedExchangeTraded2025-03-3112948539core:UnlistedNon-exchangeTraded2025-03-3112948539core:ShareCapital2025-03-3112948539core:SharePremium2025-03-3112948539core:RevaluationReserve2025-03-3112948539core:OtherReservesSubtotal2025-03-3112948539core:RetainedEarningsAccumulatedLosses2025-03-3112948539core:NetGoodwill2024-03-3112948539core:IntangibleAssetsOtherThanGoodwill2024-03-3112948539core:LandBuildings2024-03-3112948539core:PlantMachinery2024-03-3112948539core:Vehicles2024-03-3112948539core:FurnitureFittings2024-03-3112948539core:OfficeEquipment2024-03-3112948539core:AfterOneYear2024-03-3112948539core:WithinOneYear2024-03-3112948539core:ListedExchangeTraded2024-03-3112948539core:UnlistedNon-exchangeTraded2024-03-3112948539core:ShareCapital2024-03-3112948539core:SharePremium2024-03-3112948539core:RevaluationReserve2024-03-3112948539core:OtherReservesSubtotal2024-03-3112948539core:RetainedEarningsAccumulatedLosses2024-03-3112948539core:NetGoodwill2023-03-3112948539core:IntangibleAssetsOtherThanGoodwill2023-03-3112948539core:LandBuildings2023-03-3112948539core:PlantMachinery2023-03-3112948539core:Vehicles2023-03-3112948539core:FurnitureFittings2023-03-3112948539core:OfficeEquipment2023-03-3112948539core:AfterOneYear2023-03-3112948539core:WithinOneYear2023-03-3112948539core:ListedExchangeTraded2023-03-3112948539core:UnlistedNon-exchangeTraded2023-03-3112948539core:ShareCapital2023-03-3112948539core:SharePremium2023-03-3112948539core:RevaluationReserve2023-03-3112948539core:OtherReservesSubtotal2023-03-3112948539core:RetainedEarningsAccumulatedLosses2023-03-3112948539core:AfterOneYear2024-04-012025-03-3112948539core:WithinOneYear2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3112948539core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3112948539core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3112948539core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3112948539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3112948539core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3112948539core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3112948539core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3112948539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3112948539core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3112948539core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3112948539core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3112948539core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3112948539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3112948539core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3112948539core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3112948539core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3112948539core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3112948539core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3112948539bus:Director12024-04-012025-03-31

TORTOLOGY LIMITED

Registered Number
12948539
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

TORTOLOGY LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Arwind Paul Singh Jhand

Registered Address

179 Park Lane
Poynton
Stockport
SK12 1RH

Registered Number

12948539 (England and Wales)
TORTOLOGY LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets34,590-
4,590-
Current assets
Stocks4303,721247,377
Debtors11,6092,771
Cash at bank and on hand2,2251,746
317,555251,894
Creditors amounts falling due within one year5(366,721)(237,120)
Net current assets (liabilities)(49,166)14,774
Total assets less current liabilities(44,576)14,774
Creditors amounts falling due after one year6(3,500)-
Net assets(48,076)14,774
Capital and reserves
Profit and loss account(48,076)14,774
Shareholders' funds(48,076)14,774
The financial statements were approved and authorised for issue by the Director on 23 December 2025, and are signed on its behalf by:
Arwind Paul Singh Jhand
Director
Registered Company No. 12948539
TORTOLOGY LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery3
Office Equipment3
Stocks and work in progress
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
2.Average number of employees

20252024
Average number of employees during the year10
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
Additions8624,9085,770
At 31 March 258624,9085,770
Depreciation and impairment
Charge for year2459351,180
At 31 March 252459351,180
Net book value
At 31 March 256173,9734,590
At 31 March 24---
4.Stocks
Stocks are stated at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. Cost comprises direct materials, and where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

2025

2024

££
Finished goods303,721247,377
Total303,721247,377
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables1,375-
Bank borrowings and overdrafts11,535100
Amounts owed to related parties225,150235,250
Other creditors127,9411,050
Accrued liabilities and deferred income720720
Total366,721237,120
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts3,500-
Total3,500-
7.Provisions for liabilities
Provisions are made where an event has taken place that gives the company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of going the amount of the obligation. Provisions are charged as an expense to the profit and loss account in the year that the company becomes aware of the obligation and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties. When payments are eventually made, they are charged to the provision carried in the balance sheet.